Hungary - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale
Since 2014, Hungary Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale fell by 2.7% year on year. With €128,523,052.44 in 2019, the country was number 4 comparing other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale. Hungary is overtaken by Poland, which was ranked number 3 at €142,757,293.7 and is followed by France with €102,455,978.25. Germany lead the ranking with €2,350,575,277.14 in 2019, a fall of 3.4% versus 2018. Estonia recorded the best 5 years average growth at +11.1% per year, while Netherlands was the worst growing country at -38.7% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 128,523,052.44 |
| 2018 | 120,879,654.00 |
| 2017 | 127,725,822.00 |
| 2016 | 136,627,036.00 |
| 2015 | 157,000,787.00 |
Download all data from 2001 to 2019
How does Hungary rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?
| # | 17 Countries | Euros | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
2,350,575,277.14 | 2019 | -3.4 % | +8.0 % | View data |
| 2 |
#2
United Kingdom
|
195,933,082.68 | 2019 | +2.5 % | -5.9 % | View data |
| 3 |
#3
Poland
|
142,757,293.70 | 2019 | +13.0 % | -1.1 % | View data |
| 4 |
#4
Hungary
|
128,523,052.44 | 2019 | +6.3 % | -2.7 % | View data |
| 5 |
#5
France
|
102,455,978.25 | 2019 | -18.9 % | -0.0 % | View data |